KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Interest Expenses (2016 - 2026)

Idexx Laboratories has reported Interest Expenses over the past 17 years, most recently at $9.2 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 22.83% year-over-year to $9.2 million; the TTM value through Dec 2025 reached $38.9 million, up 24.51%, while the annual FY2025 figure was $38.9 million, 24.51% up from the prior year.
  • Interest Expenses for Q4 2025 was $9.2 million at Idexx Laboratories, down from $10.7 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $13.5 million in Q4 2022 and troughed at $7.0 million in Q1 2022.
  • A 5-year average of $9.1 million and a median of $8.2 million in 2022 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: surged 87.64% in 2023 and later plummeted 39.73% in 2024.
  • Year by year, Interest Expenses stood at $7.5 million in 2021, then surged by 81.18% to $13.5 million in 2022, then tumbled by 31.61% to $9.3 million in 2023, then fell by 19.07% to $7.5 million in 2024, then increased by 22.83% to $9.2 million in 2025.
  • Business Quant data shows Interest Expenses for IDXX at $9.2 million in Q4 2025, $10.7 million in Q3 2025, and $11.3 million in Q2 2025.